---
id: 217
title: Skin Abscess
category: clinical_syndromes
subcategory: skin_soft_tissue
tags: [abscess, MRSA, incision-drainage, purulent, SSTI]
difficulty: easy
---

## Question

How are skin abscesses managed? Use **"I&D = PRIMARY, Antibiotics Only if Extensive Cellulitis/Immunocompromised"** framework.

## Answer

### **Clinical Presentation:**

- **Fluctuant, tender, erythematous nodule/mass**
- **Purulent drainage** (often spontaneously draining)
- **Surrounding cellulitis** (variable)
- **Fever** (if extensive)

### **Microbiology:**

- ***Staphylococcus aureus*** (most common, 80-90%)
  - **MRSA** (60-70% of community-acquired abscesses in US)
  - **MSSA** (30-40%)
- **Streptococci** (less common)

### **Treatment:**

**1. Incision and Drainage (I&D) = PRIMARY TREATMENT:**

**Procedure:**
- **Local anesthesia** (lidocaine)
- **Incision** (large enough for drainage + exploration)
- **Break up loculations** (blunt dissection)
- **Irrigate cavity**
- **Packing** (controversial, may not be needed if small abscess)
- **Consider delayed primary closure** (if large, cosmetically sensitive area)

**I&D Alone Often Sufficient:**
- **80-90% cure rate** with I&D alone (no antibiotics)

**2. Antibiotics (Selective Use):**

**Indications for Antibiotics AFTER I&D:**
- **Extensive cellulitis** (>5 cm surrounding abscess)
- **Multiple abscesses**
- **Systemic symptoms** (fever, hypotension, tachycardia)
- **Immunocompromised** (HIV CD4 <200, neutropenia, transplant, chemotherapy, diabetes)
- **Extremes of age** (<1 year, elderly)
- **Lack of response to I&D alone**
- **Difficult to drain** (face, hand, genital area)

**Antibiotic Regimens (MRSA Coverage):**

**Outpatient:**
- **TMP-SMX DS (160/800mg) PO BID × 5-7 days** (first-line)
- **Doxycycline 100mg PO BID × 5-7 days**
- **Clindamycin 300-450mg PO TID × 5-7 days** (if local MRSA resistance <10%)

**Inpatient:**
- **Vancomycin 15-20 mg/kg IV q8-12h**
- **Alternatives:** Daptomycin 4-6 mg/kg IV daily, linezolid 600mg PO/IV BID

**Duration:** 5-7 days (if antibiotics indicated)

### **Culture:**

**Send Purulent Material for Culture:**
- **Gram stain + aerobic/anaerobic culture**
- **Helps guide therapy** (especially if antibiotics needed)
- **Identify MRSA vs MSSA** (epidemiology, adjust if needed)

### **Follow-Up:**

**Re-evaluate in 48-72 hours:**
- **Ensure clinical improvement**
- **Remove packing** (if placed, typically 24-48h)
- **Repeat I&D** if reaccumulation

**If No Improvement:**
- **Consider:** Inadequate drainage, atypical organism, immunodeficiency, underlying condition (pilonidal cyst, hidradenitis suppurativa)

### **Recurrent Abscesses:**

**Decolonization (If ≥2 Abscesses in 6 Months):**
- **Intranasal mupirocin** 2% BID × 5 days (apply to nares)
- **Chlorhexidine body wash** daily × 5-14 days
- **Decolonize household members** if recurrent infections

**Address Risk Factors:**
- **Hygiene:** Frequent handwashing, avoid sharing personal items (towels, razors)
- **Treat underlying conditions:** Hidradenitis suppurativa, pilonidal disease

### **Special Situations:**

**Perirectal Abscess:**
- **Surgical drainage** (often requires OR)
- **Antibiotics:** Metronidazole + fluoroquinolone (cover anaerobes + Gram-negatives)
- **Evaluate for Crohn disease, fistula**

**Bartholin Abscess:**
- **I&D or Word catheter** (marsupializes gland)
- **Antibiotics** (cover *E. coli*, *GC/Chlamydia*): Ceftriaxone + doxycycline

**Pilonidal Abscess:**
- **I&D** (acute)
- **Definitive surgical excision** (if recurrent)

**Hidradenitis Suppurativa:**
- **Chronic inflammatory condition** (apocrine gland inflammation)
- **Acute flare:** I&D + antibiotics (doxycycline, clindamycin)
- **Long-term:** Weight loss, smoking cessation, topical/systemic therapy (retinoids, biologics)

## Key Points

### **I&D = PRIMARY Treatment:**
- **80-90% cure** with I&D alone (no antibiotics needed)

### **Antibiotics Only if:**
- **Extensive cellulitis** (>5 cm)
- **Systemic symptoms, immunocompromised**
- **Failed I&D alone**

### **MRSA Coverage:**
- **TMP-SMX DS BID × 5-7 days** (outpatient)
- **Vancomycin** (inpatient)

### **Culture Purulent Material:**
- **Guides therapy** (MRSA vs MSSA)

### **Recurrent Abscesses:**
- **Decolonization:** Mupirocin nasal + chlorhexidine body wash
- **Treat household members** if recurrent

### **Clinical Pearls:**
- **I&D = primary treatment** (antibiotics NOT always needed)
- **Add antibiotics if:** Extensive cellulitis (>5 cm), systemic symptoms, immunocompromised
- **MRSA coverage:** TMP-SMX DS BID × 5-7 days
- **Recurrent:** Decolonization (mupirocin nasal + chlorhexidine wash × 5-14 days)
- **Culture purulent material** (guides therapy)

## Sources

- [IDSA: Skin and Soft Tissue Infection Guidelines 2024]
- [JAMA: Management of Skin Abscesses 2024]

## Media

N/A
